Subjects: LINFONODOS, DOENÇAS HEMATOLÓGICAS, INSUFICIÊNCIA RENAL, TROMBOCITOPENIA
ABNT
JOSÉ, Fabio Freire et al. A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids: The first case report in Latin America. Medicine, v. 96, n. 13, p. e6271, 2017Tradução . . Disponível em: https://doi.org/10.1097/MD.0000000000006271. Acesso em: 02 maio 2024.APA
José, F. F., Kerbauy, L. N., Perini, G. F., Blumenschein, D. I., Pasqualin, D. da C., Malheiros, D. M. A. C., et al. (2017). A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids: The first case report in Latin America. Medicine, 96( 13), e6271. doi:10.1097/MD.0000000000006271NLM
José FF, Kerbauy LN, Perini GF, Blumenschein DI, Pasqualin D da C, Malheiros DMAC, Campos Neto G de C, Piovesan R, Hamerschlak N. A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids: The first case report in Latin America [Internet]. Medicine. 2017 ; 96( 13): e6271.[citado 2024 maio 02 ] Available from: https://doi.org/10.1097/MD.0000000000006271Vancouver
José FF, Kerbauy LN, Perini GF, Blumenschein DI, Pasqualin D da C, Malheiros DMAC, Campos Neto G de C, Piovesan R, Hamerschlak N. A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids: The first case report in Latin America [Internet]. Medicine. 2017 ; 96( 13): e6271.[citado 2024 maio 02 ] Available from: https://doi.org/10.1097/MD.0000000000006271